Lymphoma, Non-Hodgkin  >>  hydrocortisone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
NCT00002552: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

Completed
2
40
US
filgrastim, sargramostim, carmustine, cyclophosphamide, cytarabine, etoposide, leucovorin calcium, methotrexate, perfosfamide, therapeutic hydrocortisone, allogeneic bone marrow transplantation, autologous bone marrow transplantation, in vitro-treated bone marrow transplantation, peripheral blood stem cell transplantation, syngeneic bone marrow transplantation, radiation therapy
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
09/01
10/03
NCT00002471: Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Completed
2
US
asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, leucovorin calcium, methotrexate, methylprednisolone, therapeutic hydrocortisone, thiotepa, vincristine sulfate
Memorial Sloan Kettering Cancer Center
Leukemia, Lymphoma
01/03
01/03
NCT00002494: Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Completed
2
134
US
cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, mesna, methotrexate, prednisone, therapeutic hydrocortisone, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Leukemia, Lymphoma
03/04
01/06
NCT00002970: 506U78 in Treating Patients With Refractory Hematologic Cancer

Completed
2
148
US
nelarabine, 506U78, Arranon, GW506U78, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, therapeutic hydrocortisone, Aeroseb-HC, Barseb HC, Cetacort, Cort-Dome, Cortef
National Cancer Institute (NCI), Children's Cancer Group
Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Childhood Acute Lymphoblastic Leukemia
01/05
 
NCT00482053: Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Terminated
2
3
US
Autologous hematopoietic stem cell transplantation (auto-HSCT), Autologous peripheral blood progenitor cell (PBPC) transplantation, Allogeneic hematopoietic stem cell transplantation (allo-HSCT), Allogeneic peripheral blood progenitor cell (PBPC) transplantation, Total lymphoid irradiation (TLI), Rituximab, Rituxan, Mabthera, Carmustine, BCNU, BiCNU, Etoposide, Eposin, Etopophos, Vepesid, VP-16, Filgrastim, Granulocyte colony-stimulating factor (G-CSF, GCSF), Colony-stimulating factor 3 (CSF-3), Anti-thymocyte globulin (ATG), Cyclosporine, Cyclosporin, CSP, Mycophenolate mofetil (MMF), CellCept, Cyclophosphamide, Cytoxan, Neosar, Acetaminophen, Tylenol, Diphenhydramine, Benadryl, Hydrocortisone, Cortef, Methylprednisolone, Solu-Medrol
Stanford University
Lymphoma, B-cell, Lymphoma, Non-Hodgkin, Diffuse Large B-cell Lymphoma (DLBCL), Malignant Lymphoma, Non-Hodgkin
05/10
05/10
NCT00392834: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

Checkmark P2 data - ASCO
Jun 2012 - Jun 2012: P2 data - ASCO
Checkmark P2 data in Burkitt's lymphoma
Dec 2011 - Dec 2011: P2 data in Burkitt's lymphoma
Completed
2
34
US
filgrastim, pegfilgrastim, rituximab, cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, liposomal cytarabine, methotrexate, therapeutic hydrocortisone, vincristine sulfate
AIDS Malignancy Consortium, National Cancer Institute (NCI), The Emmes Company, LLC
Lymphoma
07/11
07/13
NCT00133991: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia

Completed
2
23
US
Filgrastim, Neupogen, G-CSF, Rituximab, Rituxan, Cyclophosphamide, Cytoxan, Cy, CTX, HiCy, Cytarabine, Ara-C, Methotrexate, MTX, Prednisone, Deltasone, Hydrocortisone, Vincristine, Oncovin, Leucovorin, Folinic acid
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI)
Leukemia, Lymphoma
08/11
08/13
AALL07P1, NCT00873093: Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Completed
2
148
US, Canada, RoW
L-asparaginase, ASNase, Colaspase, Crasnitin, Elspar, L-ASP, doxorubicin hydrochloride, ADM, ADR, Adria, therapeutic hydrocortisone, Aeroseb-HC, Barseb HC, Cetacort, Cort-Dome, Cortef, vincristine sulfate, liposomal vincristine, Marqibo, vincristine liposomal, vincristine sulfate liposome injection, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, prednisone, DeCortin, Deltra, bortezomib, LDP 341, MLN341, VELCADE, pegaspargase, L-asparaginase with polyethylene glycol, Oncaspar, PEG-ASP, PEG-L-asparaginase, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, etoposide phosphate, ETOP, Etopophos, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, filgrastim, G-CSF, Neupogen, leucovorin calcium, CF, CFR, LV, laboratory biomarker analysis, High Dose MTX
National Cancer Institute (NCI)
B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
09/14
09/14
NCT00481832: Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

Terminated
2
50
US
Cyclophosphamide, Cytoxan, Neosar, BCNU, BiCNU, Carmustine, Etoposide, Eposin, Etopophos, VP-16, Filgrastim, Granulocyte colony-stimulating factor (G-CSF, GCSF), Colony-stimulating factor (CSF) 3, Antithymocyte globulin, ATG, Cyclosporine, cyclosporin, cyclosporin A, Mycophenolate mofetil, MMF, CellCep, Rituximab, Rituxan, MabThera, Autologous hematopoietic stem cell transplantation (auto-HSCT), Autologous peripheral blood progenitor cell (PBPC) transplantation, Allogeneic hematopoietic stem cell transplantation (allo-HSCT), Allogeneic peripheral blood progenitor cell (PBPC) transplantation, Total lymphoid irradiation, TLI, CD34+ Cells, Solu-Medrol, Methylprednisolone
Stanford University
Lymphoma, Non-Hodgkin
10/14
03/17
NCT00354107: Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma

Terminated
1/2
5
US
monoclonal antibody SGN-30, SGN-30, therapeutic hydrocortisone, Aeroseb-HC, Barseb HC, Cetacort, Cort-Dome, Cortef, ifosfamide, Cyfos, Holoxan, IFF, IFX, IPP, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, etoposide, EPEG, VP-16, VP-16-213, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, pharmacological study, pharmacological studies, laboratory biomarker analysis
National Cancer Institute (NCI)
Anaplastic Large Cell Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma
01/10
01/10

Download Options